Meet The CheckPoints: A Band of Researchers and Oncologists Giving Cancer Treble
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
The CheckPoints is a band comprised of cancer researchers, medical oncologists, and other professionals in the field of immuno-oncology.
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Experts discussed "Discovery Science in Early Cancer Biology and Interception" at a plenary during the AACR Annual Meeting 2024.
NCI Director Kimryn Rathmell evoked Taylor Swift to present her vision of the 360 era for cancer research.
Four of the 2023 GSITA recipients explain how the program has benefited their careers.
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
Dr. Edward Cliff presented a poster on the clinical benefit of cancer drugs granted accelerated approval.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
At the AACR Annual Meeting 2024, researchers discussed innovative approaches to decipher the complexities of tumor ecosystems.
Researchers at the AACR Annual Meeting 2024 presented the latest findings regarding two personalized neoantigen cancer vaccines.
During his Presidential Address at the AACR Annual Meeting 2024, Philip D. Greenberg discussed research driving immunotherapy forward.
The June edition of Editors’ Picks includes a clinical trial that clinched a new FDA approval for adagrasib, a...
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
The journey to the first approved TIL therapy began with Steven A. Rosenberg over 30 years ago.
A poster at the AACR Annual Meeting 2024 examined a video that increased awareness of prostate cancer.
Researchers are exploring new combinations of therapy, disrupting iron accumulation, and turning tumors hot in attempts to make ovarian...
Researchers discussed AI's impact on the diagnosis and treatment of cancer at the AACR Annual Meeting 2024.
The AACR Annual Meeting is the critical driver of progress against cancer, the place where scientists, clinicians, other health...
Mark your calendar! The exhibit show for the AACR Annual Meeting 2024 will be held at the San Diego...
April 5-10, 2024San Diego Convention CenterSan Diego, California Inspiring Science • Fueling Progress • Revolutionizing Care Program Committee Chairs...
AACR Virtual Meeting Platform All sessions held in the Convention Center were live-streamed to the virtual meeting platform. (Ancillary...
In support of its mission to promote the education and training of cancer scientists and clinicians, and to cultivate...
AACR Annual Meeting 2024 Mark your calendar! The AACR Annual Meeting 2024 will be held at the San Diego...
Since 1961, the AACR has been proud to recognize scientific excellence across the spectrum of basic, translational, clinical, and...
More than 240 clinical trials were presented at the AACR Annual Meeting 2024. The titles and text of the...
Beginning at 3 p.m. on Friday, April 5, and continuing all day Saturday, April 6, 2024, a program of...
All regular abstracts (submitted for the November 16, 2023 deadline) and late-breaking and clinical trial abstracts (submitted for the...
AACR Annual Meeting 2024 NextGen Stars Program The NextGen Stars program provided an exciting opportunity to increase the visibility...